Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6666
Revised: January 24, 2014
Accepted: March 4, 2014
Published online: June 7, 2014
Processing time: 213 Days and 19 Hours
AIM: To investigate the correlation of toll-like receptor 4 (TLR4) gene Asp299Gly and Thr399Ile polymorphisms and acute pancreatitis (AP) risk and severity.
METHODS: To get a more precise estimation of the relationship, a comprehensive search was performed to examine all the eligible studies of TLR4 Asp299Gly and Thr399Ile polymorphisms and AP risk. The odds ratios with 95% confidence intervals were used to assess the strength of the association. Publication bias was analyzed by Begg’s funnel plots.
RESULTS: In total, six studies with 1255 cases and 998 controls were included in this meta-analysis. Totally, no significant associations were found between TLR4 Asp299Gly or Thr399Ile polymorphisms and AP risk using five models with high homogeneity (P > 0.05). Furthermore, stratification analysis by ethnicity or assay also found no significant association in these two polymorphisms (P > 0.05), and TLR4 Asp299Gly was not associated with AP severity (P > 0.05). In addition, no publication bias was found in these studies (P > 0.05).
CONCLUSION: Our current meta-analysis suggests that TLR4 Asp299Gly and Thr399Ile polymorphisms may not be risk factors to AP susceptibility.
Core tip: Toll-like receptor 4 (TLR4) is one of the central proinflammatory factors in the pathology of acute pancreatitis (AP). Nevertheless, the relationship between TLR4 polymorphisms and AP susceptibility has been controversial. Here, we performed a systematic meta-analysis of TLR4 polymorphisms and AP risk, and our data showed that TLR4 Asp299Gly and Thr399Ile polymorphisms may not be associated with AP susceptibility.